Replies to post #87017 on Anavex Life Sciences Corp (AVXL)

[LakeshoreLeo1953]

There would be NO reason for a Partnership except to pursue P3.
BP not going to write a check for salaries and extended P2.
Same difference.

[XenaLives]

The FDA could also approve based on P2 data, giving a path to mid to late 2017 approval.

Standards for Medical Products

While the act reduces or simplifies many regulatory obligations of manufacturers, it does not lower the standards by which medical products are introduced into the market place. In the area of drugs, the law codifies the agency's current practice of allowing in certain circumstances one clinical investigation as the basis for product approval. The act, however, does preserve the presumption that, as a general rule, two adequate and well-controlled studies are needed to prove the product's safety and effectiveness.

http://www.fda.gov/RegulatoryInformation/Legislation/SignificantAmendmentstotheFDCAct/FDAMA/ucm089179.htm

[Maple tree]

Make sense